Enovis (ENOV) Retained Earnings (2010 - 2026)
Enovis' (ENOV) quarterly Retained Earnings came in at -$103.8 million in Q2 2026, up 69.39% year-on-year from -$61.3 million in Q2 2025, and down 13.57% on a QoQ basis from -$91.4 million in Q4 2025.
Enovis (ENOV) Retained Earnings (2010 - 2026) Analysis & Trends
Enovis (ENOV) has 17 years of Retained Earnings data on file, last reported at -$103.8 million in Q2 2026.
- On a quarterly basis, Retained Earnings rose 69.39% year-over-year to -$103.8 million in Q2 2026; TTM through Apr 2026 was -$103.8 million, a 69.39% increase from a year earlier, with the FY2025 full-year figure at -$91.4 million, up 28.56% from the prior year.
- Retained Earnings for Q2 2026 stood at -$103.8 million, down from -$91.4 million in the prior quarter.
- Over the last five years, Retained Earnings for ENOV reached as high as $3.0 billion in Q4 2025 and fell as low as -$339.0 million in Q2 2025.
- Historically, Retained Earnings has averaged $714.9 million across 5 years, with a median of -$22.5 million in 2023.
- Across the five-year window, Retained Earnings slumped 179.83% in 2023 and surged 139826.53% in 2024, its largest moves.
- Year by year, Retained Earnings stood at -$116.6 million in 2022, then jumped by 565.2% to $542.5 million in 2023, then slumped by 123.58% to -$127.9 million in 2024, then rose by 28.56% to -$91.4 million in 2025, then fell by 13.57% to -$103.8 million in 2026.
- Per Business Quant data, the three most recent Retained Earnings figures were -$103.8 million in Q2 2026, -$91.4 million in Q4 2025, and $3.0 billion in Q4 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | -6.31 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -583.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | -4.10 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 6.91 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 14.62 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 2.63 Bn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | - |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | -1.40 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 5.32 Bn |
| 10 | Enovis | 1.50 Bn | 1.47 Bn | 365.49 Mn | -103.76 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 3, 2026 | -103.76 Mn |
| Dec 31, 2025 | -91.36 Mn |
| Oct 3, 2025 | 3.04 Bn |
| Jul 4, 2025 | -77.24 Mn |
| Apr 4, 2025 | -338.99 Mn |
| Dec 31, 2024 | -127.89 Mn |
| Sep 27, 2024 | 2.96 Bn |
| Jun 28, 2024 | 2.91 Bn |
| Mar 29, 2024 | 2.90 Bn |
| Dec 31, 2023 | 542.47 Mn |
| Sep 29, 2023 | -2.12 Mn |
| Jun 30, 2023 | 11.71 Mn |
| Mar 31, 2023 | -42.87 Mn |
| Sep 30, 2022 | -116.61 Mn |
| Jul 1, 2022 | -88.94 Mn |
| Apr 1, 2022 | 53.70 Mn |
| Dec 31, 2021 | 44.67 Mn |
| Oct 1, 2021 | -459.87 Mn |
| Jul 2, 2021 | -482.62 Mn |
| Apr 2, 2021 | -111.02 Mn |